Jan Wolpert is the founder and principal owner of Wolpert Associates, Inc. (“WAI”) d/b/a Wolpert Advisors. Acting as both a strategic advisor and entrepreneur, he works with companies in the biomedical sector – primarily biopharmaceuticals and medical technology. Based in New York City, his business interests are global – mirroring the global dimensions of biomedical innovation.
Spanning a career of over 35 years in both general management and strategic development, he has led the conceptualization and execution of hundreds of complex corporate development and new venture transactions and initiatives across all health care and life science sectors, as well as other rapidly changing industries. Jan has conducted business through WAI since 2010, and prior (2004-2010) he was the CEO of Clearview Projects, Inc. (Princeton, NJ USA), a boutique strategic transaction advisory firm devoted to the global biopharma segment. Before leading Clearview, Mr. Wolpert was Vice President - Corporate Development at Pharmacia (now an affiliate of Pfizer) and its predecessor Monsanto Company (1996-2003), and in the formative years of his career (starting in the mid 1980’s) was a principal with several large strategic consulting firms. He holds an M.B.A. degree from The Wharton School of the University of Pennsylvania and a B.S. in electrical engineering from The University of Maryland at College Park.
